Literature DB >> 16115880

Docking and rolling, a model of how the mitotic motor Eg5 works.

Steven S Rosenfeld1, Jun Xing, Geraldine M Jefferson, Peter H King.   

Abstract

Whereas kinesin I is designed to transport cargoes long distances in isolation, a closely related kinesin motor, Eg5, is designed to generate a sustained opposing force necessary for proper mitotic spindle formation. Do the very different roles for these evolutionarily related motors translate into differences in how they generate movement? We have addressed this question by examining when in the ATPase cycle the Eg5 motor domain and neck linker move through the use of a series of novel spectroscopic probes utilizing fluorescence resonance energy transfer, and we have compared our results to kinesin I. Our results are consistent with a model in which movement in Eg5 occurs in two sequential steps, an ATP-dependent docking of the neck linker, followed by a rotation or "rolling" of the entire motor domain on the microtubule surface that occurs with ATP hydrolysis. These two forms of movement are consistent with the functions of a motor designed to generate sustained opposing force, and hence, our findings support the argument that the mechanochemical features of a molecular motor are shaped more by the demands placed on it than by its particular family of origin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115880     DOI: 10.1074/jbc.M506561200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  The loop 5 element structurally and kinetically coordinates dimers of the human kinesin-5, Eg5.

Authors:  Joshua S Waitzman; Adam G Larson; Jared C Cochran; Nariman Naber; Roger Cooke; F Jon Kull; Edward Pate; Sarah E Rice
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

2.  Modulation of the kinesin ATPase cycle by neck linker docking and microtubule binding.

Authors:  Yu Cheng Zhao; F Jon Kull; Jared C Cochran
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

3.  The structural kinetics of switch-1 and the neck linker explain the functions of kinesin-1 and Eg5.

Authors:  Joseph M Muretta; Yonggun Jun; Steven P Gross; Jennifer Major; David D Thomas; Steven S Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

4.  Individual dimers of the mitotic kinesin motor Eg5 step processively and support substantial loads in vitro.

Authors:  Megan T Valentine; Polly M Fordyce; Troy C Krzysiak; Susan P Gilbert; Steven M Block
Journal:  Nat Cell Biol       Date:  2006-04-02       Impact factor: 28.824

Review 5.  To step or not to step? How biochemistry and mechanics influence processivity in Kinesin and Eg5.

Authors:  Megan T Valentine; Susan P Gilbert
Journal:  Curr Opin Cell Biol       Date:  2006-12-26       Impact factor: 8.382

6.  Dimeric Eg5 maintains processivity through alternating-site catalysis with rate-limiting ATP hydrolysis.

Authors:  Troy C Krzysiak; Susan P Gilbert
Journal:  J Biol Chem       Date:  2006-10-23       Impact factor: 5.157

Review 7.  Kinesin motor mechanics: binding, stepping, tracking, gating, and limping.

Authors:  Steven M Block
Journal:  Biophys J       Date:  2007-02-26       Impact factor: 4.033

8.  Getting in sync with dimeric Eg5. Initiation and regulation of the processive run.

Authors:  Troy C Krzysiak; Michael Grabe; Susan P Gilbert
Journal:  J Biol Chem       Date:  2007-11-25       Impact factor: 5.157

9.  Loop L5 assumes three distinct orientations during the ATPase cycle of the mitotic kinesin Eg5: a transient and time-resolved fluorescence study.

Authors:  Joseph M Muretta; William M Behnke-Parks; Jennifer Major; Karl J Petersen; Adeline Goulet; Carolyn A Moores; David D Thomas; Steven S Rosenfeld
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

10.  Force and premature binding of ADP can regulate the processivity of individual Eg5 dimers.

Authors:  Megan T Valentine; Steven M Block
Journal:  Biophys J       Date:  2009-09-16       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.